K. Devendra
Pfizer (United States)(US)
Publications by Year
Research Areas
Animal Disease Management and Epidemiology, Viral Infections and Immunology Research, SARS-CoV-2 and COVID-19 Research, Maternal and Perinatal Health Interventions, COVID-19 Clinical Research Studies
Most-Cited Works
- → An oral SARS-CoV-2 M pro inhibitor clinical candidate for the treatment of COVID-19(2021)1,855 cited
- → Biochemical Mechanism of HIV-1 Resistance to Rilpivirine(2012)69 cited
- → A Second-Generation Oral SARS-CoV-2 Main Protease Inhibitor Clinical Candidate for the Treatment of COVID-19(2024)61 cited
- → The Roles of Picornavirus Untranslated Regions in Infection and Innate Immunity(2018)51 cited
- → Attenuation of Foot-and-Mouth Disease Virus by Engineered Viral Polymerase Fidelity(2017)50 cited
- B-Lynch suture for the treatment of uterine atony.(2009)
- → Should Doctors Perform an Elective Caesarean Section on Request?(2003)43 cited
- → Nirmatrelvir, Molnupiravir, and Remdesivir maintain potent in vitro activity against the SARS-CoV-2 Omicron variant(2022)35 cited
- → In vitro selection and analysis of SARS-CoV-2 nirmatrelvir resistance mutations contributing to clinical virus resistance surveillance(2024)35 cited
- → Nirmatrelvir, an orally active Mpro inhibitor, is a potent inhibitor of SARS-CoV-2 Variants of Concern(2022)33 cited